PB-22
法律規範狀態 | |
---|---|
法律規範 |
|
識別資訊 | |
| |
CAS號 | 1400742-17-7 |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.233.114 |
化學資訊 | |
化學式 | C23H22N2O2 |
摩爾質量 | 358.44 g·mol−1 |
3D模型(JSmol) | |
| |
|
PB-22是一種狡詐家藥物,化學式為C23H22N2O2,它在網絡上作為大麻模擬劑供應,並在2013年於日本的合成大麻產品被發現。[1][2]PB-22在其吲哚環的3號位有酯基,可以被視作一類具有獨特結構的合成大麻素。它在2014年於新西蘭[3]、同年於美國管控。[4][5]
參考文獻
- ^ Uchiyama N, Matsuda S, Kawamura M, Kikura-Hanajiri R, Goda Y. Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products. Forensic Toxicology. 2013, 31 (2): 223–240. S2CID 1279637. doi:10.1007/s11419-013-0182-9.
- ^ Lin M, Ellis B, Eubanks LM, Janda KD. Pharmacokinetic Approach to Combat the Synthetic Cannabinoid PB-22. ACS Chemical Neuroscience. July 2021, 12 (14): 2573–2579. PMID 34254505. S2CID 235808519. doi:10.1021/acschemneuro.1c00360.
- ^ Jones N. Legal highs pulled from shelves. New Zealand Herald. New Zealand Media and Entertainment. 1 May 2014 [18 August 2020]. (原始內容存檔於2017-12-01).
- ^ Behonick G, Shanks KG, Firchau DJ, Mathur G, Lynch CF, Nashelsky M, et al. Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22. Journal of Analytical Toxicology. October 2014, 38 (8): 559–562. PMC 4334789 . PMID 24876364. doi:10.1093/jat/bku048.
- ^ PB-22 and 5F-PB-22 (PDF). DEA, Office of Diversion Control. [2023-11-24]. (原始內容存檔 (PDF)於2024-05-21).